Loading clinical trials...
Loading clinical trials...
Randomized Phase III Study Comparison Between Conventional Chemotherapy and High-Dose Therapy Followed by Autologous Purged Stem-Cell Transplantation in Patients With Follicular Lymphoma Stage III,IV First-Line Treatment for Patients Younger Than 60 Years Old With a High Tumor Burden
Conditions
Interventions
chemotherapy
high dose therapy and autologous stem cell transplantation
Locations
2
France
Emmanuel GYAN
Tours, France
Philippe COLOMBAT
Tours, France
Start Date
June 1, 1994
Primary Completion Date
May 1, 2003
Completion Date
May 1, 2006
Last Updated
October 24, 2008
NCT06337318
NCT05006716
NCT06026319
NCT07128641
NCT06510361
NCT01804686
Lead Sponsor
French Innovative Leukemia Organisation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions